Mathias Hougaard Loft

Mathias Hougaard Loft

Ph.d.-studerende


Udgivelsesår:
Alle
1 - 3 ud af 3Pr. side: 10
Sortering: Udgivelsesdato
  1. 2022
  2. Udgivet

    First-in-Human PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic

    Loft, Mathias Hougaard, Christensen, C., Clausen, Malene Martini, Carlsen, Esben Andreas, Hansen, C. P., Kroman, Niels Thorndahl, Langer, Seppo W., Høgdall, Claus Kim, Madsen, J., Gillings, N., Nielsen, Carsten Haagen, Klausen, Thomas Levin, Holm, S., Loft, A., Berthelsen, A. K. & Kjær, Andreas, 2022, I: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 63, 12, s. 1871-1879

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

  3. Udgivet

    Prospective phase II trial of prognostication by 68Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy

    Carlsen, Esben Andreas, Loft, Mathias Hougaard, Loft, A., Berthelsen, A. K., Langer, Seppo W., Knigge, Ulrich & Kjær, Andreas, 2022, I: Journal of Nuclear Medicine. 63, 9, s. 1371-1377

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

  4. Udgivet

    Reduction of 64Cu-DOTATATE activity dose for somatostatin receptor PET imaging of patients with neuroendocrine neoplasms

    Loft, Mathias Hougaard, Carlsen, Esben Andreas, Johnbeck, C. B., Jensen, C. V., Andersen, Flemming Littrup, Langer, Seppo W., Otorai, P., Knigge, Ulrich & Kjær, Andreas, 2022, I: Journal of Neuroendocrinology. 34, S1, s. 151-151 1 s.

    Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt

ID: 257010049